Aquestive Therapeutics Dividend
Dividend criteria checks 0/6
Aquestive Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.3% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$0.086 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Aquestive Therapeutics: Positive Phase III Data Unlocks Additional Catalysts For 2024
Apr 09Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) Shares Climb 30% But Its Business Is Yet to Catch Up
Feb 28Aquestive Therapeutics: Anaphylm's Top-Line Data Could Reveal A Game-Changer In Q1
Jan 19Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) Popularity With Investors Is Under Threat From Overpricing
Jan 05Aquestive Therapeutics, Inc. (NASDAQ:AQST) Surges 63% Yet Its Low P/S Is No Reason For Excitement
Apr 17Aquestive Therapeutics receives positive FDA response for AQST-109 epinephrine for severe allergic reaction
Oct 11Aquestive Therapeutics, Pharmanovia ink licensing & supply pact for Libervant buccal film
Sep 28Aquestive Therapeutics: FDA Stymies Libervant Launch
Sep 05Aquestive Therapeutics: A First Take
Aug 29Aquestive Therapeutics: Sell-Off Prompts A Change In Tactics
May 26Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if AQST's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AQST's dividend payments have been increasing.
Dividend Yield vs Market
Aquestive Therapeutics Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (AQST) | n/a |
Market Bottom 25% (US) | 1.6% |
Market Top 25% (US) | 4.8% |
Industry Average (Pharmaceuticals) | 2.3% |
Analyst forecast in 3 Years (AQST) | n/a |
Notable Dividend: Unable to evaluate AQST's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate AQST's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate AQST's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as AQST has not reported any payouts.